Form 4: Glaukos Corp Executive Navratil Reports Stock Award Vesting

Chief Development Officer Tomas Navratil reports the vesting of restricted stock units tied to Glaukos Corp's operational targets.

Summary

• On March 14, 2024, Tomas Navratil, Chief Development Officer of Glaukos Corporation, reported the vesting of restricted stock units.
• These units are tied to the achievement of pre-determined operational targets over a multi-year performance period.
• The Compensation, Nominating & Governance Committee determined that certain operational targets had been achieved.
• A total of 1,950 shares vested from a grant on March 18, 2021, and 1,027 shares vested from a grant on March 24, 2022.
• Additionally, 11,075 restricted stock units vested, granted over a four-year period with 25% vesting annually.
• 50% of the shares from the March 2021 and March 2022 grants will be delivered in March 2024, and the remaining 50% in December 2024.
• Following these transactions, Navratil beneficially owns 79,648 shares of Glaukos Corp common stock, including unvested restricted stock units.

Sentiment

Score: 7

Explanation: The document is generally positive as it indicates the achievement of operational targets, leading to the vesting of executive stock awards. This suggests the company is performing as expected.

Positives

• The vesting of restricted stock units indicates that Glaukos Corp has achieved certain operational targets, which is a positive sign for the company's performance.
• The structure of the vesting schedule, with portions vesting in both March and December 2024, may provide ongoing motivation for the executive.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of stock units tied to operational targets suggests an expectation of continued performance.

Industry Context

Executive compensation and stock ownership are common practices in publicly traded companies to align management's interests with those of shareholders. The vesting of restricted stock units based on performance targets is a typical incentive mechanism.

Comparison to Industry Standards

• Stock-based compensation is a standard practice among publicly traded companies, particularly in the technology and healthcare sectors, to incentivize executives and align their interests with shareholder value.
• Vesting schedules tied to performance metrics are also common, with the specific metrics varying based on the company's strategic goals.
• Comparable companies in the medical device industry, such as STAAR Surgical or InMode, also utilize stock options and restricted stock units as part of their executive compensation packages.

Stakeholder Impact

• The vesting of stock units can positively impact shareholders by aligning executive interests with company performance.
• Employees may be motivated by the company's achievement of operational targets.

Key Dates